{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T08:05:25Z","timestamp":1769501125929,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T00:00:00Z","timestamp":1397606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s12032-014-0933-4","type":"journal-article","created":{"date-parts":[[2014,4,15]],"date-time":"2014-04-15T08:06:52Z","timestamp":1397549212000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Clinical significance of Wnt-11 and squamous cell carcinoma antigen expression in cervical cancer"],"prefix":"10.1007","volume":"31","author":[{"given":"Heng","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoao","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingshuang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youbo","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shulan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,16]]},"reference":[{"key":"933_CR1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s10637-009-9240-x","volume":"28","author":"M Singh","year":"2010","unstructured":"Singh M, Tyagi S, Bhui K, Prasad S, Shukla Y. Regulation of cell growth through cell cycle arrest and apoptosis in HPV 16 positive human cervical cancer cells by tea polyphenols. Invest New Drugs. 2010;28:216\u201324.","journal-title":"Invest New Drugs"},{"key":"933_CR2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"H Zur Hausen","year":"2002","unstructured":"Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342\u201350.","journal-title":"Nat Rev Cancer"},{"key":"933_CR3","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1158\/0008-5472.CAN-05-0455","volume":"65","author":"A Uren","year":"2005","unstructured":"Uren A, Fallen S, Yuan H, Usub\u00fct\u00fcn A, K\u00fc\u00e7\u00fckali T, Schlegel R, Toretsky JA. Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression. Cancer Res. 2005;65:6199\u2013206.","journal-title":"Cancer Res"},{"key":"933_CR4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1755-7682-1-10","volume":"1","author":"C Perez-Plasencia","year":"2008","unstructured":"Perez-Plasencia C, Duenas-Gonzalez A, Alatorre-Tavera B. Second hit in cervical carcinogenesis process: involvement of wnt\/beta catenin pathway. Int Arch Med. 2008;1:10.","journal-title":"Int Arch Med"},{"key":"933_CR5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrc2389","volume":"8","author":"A Klaus","year":"2008","unstructured":"Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer. 2008;8:387\u201398.","journal-title":"Nat Rev Cancer"},{"key":"933_CR6","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1146\/annurev.cellbio.20.010403.113126","volume":"20","author":"CY Logan","year":"2004","unstructured":"Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004;20:781\u2013810.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"933_CR7","doi-asserted-by":"crossref","first-page":"26707","DOI":"10.1074\/jbc.M402877200","volume":"279","author":"L Ouko","year":"2004","unstructured":"Ouko L, Ziegler TR, Gu LH, Eisenberg LM, Yang VW. Wnt11 signaling promotes proliferation, transformation, and migration of IEC6 intestinal epithelial cells. J Biol Chem. 2004;279:26707\u201315.","journal-title":"J Biol Chem"},{"key":"933_CR8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1476-4598-9-55","volume":"9","author":"P Uysal-Onganer","year":"2010","unstructured":"Uysal-Onganer P, Kawano Y, Caro M, Walker MM, Diez S, Darrington RS, Waxman J, Kypta RM. Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells. Mol Cancer. 2010;9:55.","journal-title":"Mol Cancer"},{"key":"933_CR9","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.1158\/0008-5472.CAN-04-2704","volume":"64","author":"H Zhu","year":"2004","unstructured":"Zhu H, Mazor M, Kawano Y, Walker MM, Leung HY, Armstrong K, Waxman J, Kypta RM. Analysis of Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the androgen receptor. Cancer Res. 2004;64:7918\u201326.","journal-title":"Cancer Res"},{"key":"933_CR10","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1200\/JCO.2001.19.19.3960","volume":"19","author":"MD Esajas","year":"2001","unstructured":"Esajas MD, Duk JM, de Bruijn HW, Aalders JG, Willemse PH, Sluiter W, Pras B, ten Hoor K, Hollema H, van der Zee AG. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer. J Clin Oncol. 2001;19:3960\u20136.","journal-title":"J Clin Oncol"},{"key":"933_CR11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0360-3016(01)01805-3","volume":"52","author":"E Pras","year":"2002","unstructured":"Pras E, Willemse PH, Canrinus AA, de Bruijn HW, Sluiter WJ, ten Hoor KA, Aalders JG, Szabo BG, de Vries EG. Serum squamous cell carcinoma antigen and CYFRA 21-1 in cervical cancer treatment. Int J Radiat Oncol Biol Phys. 2002;52:23\u201332.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"933_CR12","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1158\/1078-0432.CCR-08-0346","volume":"14","author":"SH Yuan","year":"2008","unstructured":"Yuan SH, Liang XF, Jia WH, Huang JL, Wei M, Deng L, Liang LZ, Wang XY, Zeng YX. Molecular diagnosis of sentinel lymph node metastases in cervical cancer using squamous cell carcinoma antigen. Clin Cancer Res. 2008;14:5571\u20138.","journal-title":"Clin Cancer Res"},{"key":"933_CR13","first-page":"17","volume":"23","author":"CC Yuan","year":"2002","unstructured":"Yuan CC, Wang PH, Ng HT, Tsai LC, Juang CM, Chiu LM. Both TPA and SCC-Ag levels are prognostic even in high-risk stage Ib-IIa cervical carcinoma as determined by a stratification analysis. Eur J Gynaecol Oncol. 2002;23:17\u201320.","journal-title":"Eur J Gynaecol Oncol"},{"key":"933_CR14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000073846","volume":"24","author":"R Molina","year":"2003","unstructured":"Molina R, Filella X, Lejarcegui JA, Pahisa J, Torn\u00e9 A, Rovirosa A, Mellado B, Ordi J, Puig-Tintore LM, Alicarte J, Biete A, Iglesias J. Prospective evaluation of squamous cell carcinoma and carcinoembryonic antigen as prognostic factors in patients with cervical cancer. Tumour Biol. 2003;24:156\u201364.","journal-title":"Tumour Biol"},{"key":"933_CR15","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1200\/JCO.2005.02.123","volume":"23","author":"N Reesink-Peters","year":"2005","unstructured":"Reesink-Peters N, van der Velden J, Ten Hoor KA, Boezen HM, de Vries EG, Schilthuis MS, Mourits MJ, Nijman HW, Aalders JG, Hollema H, Pras E, Duk JM, van der Zee AG. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer. J Clin Oncol. 2005;23:1455\u201362.","journal-title":"J Clin Oncol"},{"key":"933_CR16","first-page":"1745","volume":"11","author":"M Porika","year":"2010","unstructured":"Porika M, Vemunoori AK, Tippani R, Mohammad A, Bollam SR, Abbagani S. Squamous cell carcinoma antigen and cancer antigen 125 in southern Indian cervical cancer patients. Asian Pac J Cancer Prev. 2010;11:1745\u20137.","journal-title":"Asian Pac J Cancer Prev"},{"key":"933_CR17","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1158\/0008-5472.CAN-06-3696","volume":"67","author":"Z Lin","year":"2007","unstructured":"Lin Z, Reierstad S, Huang CC, Bulun SE. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer. Cancer Res. 2007;67:5017\u201324.","journal-title":"Cancer Res"},{"key":"933_CR18","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ejogrb.2011.07.001","volume":"159","author":"K Hashimoto","year":"2011","unstructured":"Hashimoto K, Yonemori K, Katsumata N, Hirakawa A, Hirata T, Yamamoto H, Shimizu C, Tamura K, Ando M, Fujiwara Y. Use of squamous cell carcinoma antigen as a biomarker of chemotherapy response in patients with metastatic cervical carcinoma. Eur J Obstet Gynecol Reprod Biol. 2011;159:394\u20138.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"933_CR19","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1038\/onc.2010.582","volume":"30","author":"LH Mochmann","year":"2011","unstructured":"Mochmann LH, Bock J, Ortiz-T\u00e1nchez J, Schlee C, Bohne A, Neumann K, Hofmann WK, Thiel E, Baldus CD. Genome-wide screen reveals WNT11, a non-canonical WNT gene, as a direct target of ETS transcription factor ERG. Oncogene. 2011;30:2044\u201356.","journal-title":"Oncogene"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-014-0933-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-014-0933-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-014-0933-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T10:52:18Z","timestamp":1565347938000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-014-0933-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,16]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["933"],"URL":"https:\/\/doi.org\/10.1007\/s12032-014-0933-4","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,16]]},"article-number":"933"}}